Literature DB >> 22080961

Duration and magnitude of hypotension and monocyte deactivation in patients with community-acquired pneumonia.

Peter M Simon1, Russell L Delude, MinJae Lee, Lan Kong, Lynda J Guzik, David T Huang, Derek C Angus, John A Kellum.   

Abstract

The objective was to examine the relationship of duration and magnitude of arterial hypotension to subsequent cellular immune suppression and cytokinemia in patients hospitalized with community-acquired pneumonia (CAP). We studied an observational cohort of 525 subjects hospitalized after presenting to the emergency department with radiographic and clinical signs of CAP. We compared the duration and magnitude of hypotension, using the cardiovascular Sequential Organ Failure Assessment (CV SOFA) subscore, to day 3 monocyte expression of human leukocyte antigen-DR (mHLA-DR), a previously validated marker of cellular immune suppression. A significant association of CV SOFA with decreased mHLA-DR expression was present in univariate analysis (P < 0.001) and persisted after adjustment for illness severity and other covariates (P = 0.01). With CV SOFA separated into components of magnitude and duration, after covariate adjustment, only duration was associated with day 3 mHLA-DR expression (P = 0.03). Levels of key proinflammatory and anti-inflammatory cytokines (interleukin 6 [IL-6], IL-10, tumor necrosis factor) increased with hypotension exposure and were also associated with mHLA-DR expression. In patients admitted with CAP, arterial hypotension over the first 3 days is associated with markers of monocyte deactivation. The duration of exposure to hypotension may be more important than the magnitude, and monocyte deactivation correlates with IL-6 and IL-10 release. These results suggest that persistent hypotension might contribute to immunosuppression following septic shock.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080961      PMCID: PMC3259126          DOI: 10.1097/SHK.0b013e318235331e

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  34 in total

Review 1.  New strategies for clinical trials in patients with sepsis and septic shock.

Authors:  J Cohen; G Guyatt; G R Bernard; T Calandra; D Cook; D Elbourne; J Marshall; A Nunn; S Opal
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

2.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

3.  Surviving intensive care: a report from the 2002 Brussels Roundtable.

Authors:  Derek C Angus; Jean Carlet
Journal:  Intensive Care Med       Date:  2003-01-21       Impact factor: 17.440

4.  Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study.

Authors:  Wolf-Dietrich Döcke; Conny Höflich; Kenneth A Davis; Karsten Röttgers; Christian Meisel; Paul Kiefer; Stefan U Weber; Monika Hedwig-Geissing; Ernst Kreuzfelder; Peter Tschentscher; Thomas Nebe; Andrea Engel; Guillaume Monneret; Andreas Spittler; Kathrin Schmolke; Petra Reinke; Hans-Dieter Volk; Dagmar Kunz
Journal:  Clin Chem       Date:  2005-10-07       Impact factor: 8.327

Review 5.  Hemorrhage and resuscitation: immunological aspects.

Authors:  I H Chaudry; A Ayala; W Ertel; R N Stephan
Journal:  Am J Physiol       Date:  1990-10

6.  Mechanism of immunosuppression following hemorrhage: defective antigen presentation by macrophages.

Authors:  R N Stephan; A Ayala; J M Harkema; R E Dean; J R Border; I H Chaudry
Journal:  J Surg Res       Date:  1989-06       Impact factor: 2.192

7.  The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration.

Authors:  Guillaume Monneret; Marie-Emmanuelle Finck; Fabienne Venet; Anne-Lise Debard; Julien Bohé; Jacques Bienvenu; Alain Lepape
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

8.  The sepsis seesaw: tilting toward immunosuppression.

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Jonathan E McDunn; Thomas A Ferguson
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

9.  Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis.

Authors:  R N Stephan; T S Kupper; A S Geha; A E Baue; I H Chaudry
Journal:  Arch Surg       Date:  1987-01

10.  Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis.

Authors:  Neslihan Cabioglu; Sema Bilgic; Gunnur Deniz; Esin Aktas; Yalcýn Seyhun; Akif Turna; Kayhan Gunay; Figen Esen
Journal:  Arch Surg       Date:  2002-09
View more
  6 in total

1.  Hospital-based acute care use in survivors of septic shock.

Authors:  Alexandra Ortego; David F Gaieski; Barry D Fuchs; Tiffanie Jones; Scott D Halpern; Dylan S Small; S Cham Sante; Byron Drumheller; Jason D Christie; Mark E Mikkelsen
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

2.  Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.

Authors:  Stephen Y Liang; Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

3.  HLA-DR expression, cytokines and bioactive lipids in sepsis.

Authors:  Undurti Das
Journal:  Arch Med Sci       Date:  2014-05-13       Impact factor: 3.318

4.  The duration of hypotension determines the evolution of bacteremia-induced acute kidney injury in the intensive care unit.

Authors:  Karin Janssen van Doorn; Walter Verbrugghe; Kristien Wouters; Hilde Jansens; Philippe G Jorens
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

5.  Long-Term Abnormalities of Lipid Profile After a Single Episode of Sepsis.

Authors:  Nicholas Felici; Da Liu; Josh Maret; Mariana Restrepo; Yuliya Borovskiy; Jihane Hajj; Wesley Chung; Krzysztof Laudanski
Journal:  Front Cardiovasc Med       Date:  2021-11-15

Review 6.  An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.

Authors:  Anand Kumar
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.